Vermillion Wealth Management’s Ingevity NGVT Stock Holding History

Vermillion Wealth Management’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3	Closed	-$214	–	2139
2026 Q1	$214	Buy	+3	New	+$205	﹤0.01%	1301

Other funds holding NGVT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vermillion Wealth Management's NGVT Position: Q2 2026 in Review

Vermillion Wealth Management sold out of Ingevity (NGVT) in Q2 2026, closing a stake of 3 shares — an estimated $214 sold.

Vermillion Wealth Management first reported a position in NGVT in Q1 2026 and held it in 1 quarter. The position peaked at $214 in Q1 2026. 315 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

Vermillion Wealth Management reported no remaining Ingevity position as of Q2 2026 after selling out during the quarter.
Vermillion Wealth Management sold 3 Ingevity shares in Q2 2026, an estimated $214.
Vermillion Wealth Management first reported a position in Ingevity in Q1 2026 and held it in 1 quarter.
Vermillion Wealth Management's Ingevity position peaked at $214 in Q1 2026.
315 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.